Mice Selected for Acute Inflammation Present Altered Immune Response during Pristane-Induced Arthritis Progression

Area of Science:

• Immunology
• Rheumatology
• Genetics

Background:

• Pristane-induced arthritis (PIA) is a model for autoimmune diseases.
• Genetic background influences arthritis severity and immune response.
• Understanding immune mechanisms in PIA is crucial for therapeutic development.

Purpose of the Study:

• To investigate the role of genetic selection for inflammatory response in PIA.
• To characterize immune cell profiles and cytokine production in susceptible (AIRmax) and resistant (AIRmin) mice during PIA.
• To identify potential therapeutic targets for arthritis.

Main Methods:

• Utilized mouse lines selected for maximal (AIRmax) and minimal (AIRmin) acute inflammatory reactions.
• Induced arthritis using pristane in selected mouse lines.
• Analyzed cellular profiles (lymphocytes, monocytes/macrophages, neutrophils) and measured cytokine levels (IL-1β, IFN-γ, TNF-α, IL-10) and total IgG3.
• Monitored spleen and thymus weight alterations during PIA progression.

Main Results:

• AIRmax mice showed exacerbated cellular infiltration (lymphocytes, monocytes/macrophages, neutrophils) during PIA.
• Higher production of IL-1β, IFN-γ, TNF-α, IL-10, total IgG3, and chemokines was observed in AIRmax mice.
• AIRmin mice demonstrated more efficient control of cell activation during arthritis progression.
• Significant weight alterations in spleen and thymus were noted in both groups during PIA.

Conclusions:

• Genetic selection for inflammatory response significantly impacts arthritis severity in PIA.
• AIRmax mice exhibit a pro-inflammatory immune profile contributing to cartilage damage and disease severity.
• AIRmin mice possess mechanisms for controlling immune cell activation, leading to milder disease.
• Identified immune mechanisms and genetic factors in AIRmax mice represent potential therapeutic targets for arthritis.